title: Site-specific immune suppression with topical cyclosporine. Synergism with combined topical corticosteroid added during the maintenance phase.
authors.affiliation: Department of Surgery, University of California, Irvine 92717, USA.
authors.forename: R
authors.initials: R
authors.lastname: Llull
authors.forename: T P
authors.initials: TP
authors.lastname: Lee
authors.forename: A N
authors.initials: AN
authors.lastname: Vu
authors.forename: K S
authors.initials: KS
authors.lastname: Black
authors.forename: C W
authors.initials: CW
authors.lastname: Hewitt
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000818:Animals; D000917:Antibody Formation; D016572:Cyclosporine / Q000008:administration & dosage*; D004357:Drug Synergism; D006085:Graft Survival / Q000187:drug effects; D006854:Hydrocortisone / Q000494:pharmacology; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D016038:Skin Transplantation / Q000276:immunology*; D013997:Time Factors
chemical_list: D000276:Adjuvants, Immunologic; D000305:Adrenal Cortex Hormones; D016572:Cyclosporine; D006854:Hydrocortisone